The chronic inflammafion in asthma is due largely to the persistence of Th2 lymphocytes and Th2 cytokines/chemokines produced by both the structural cells of the lung as well as the infiltrating CD4+ lymphocytes, eosinophils, and basophils and the resident mast cells, leading to progressive loss of lung funcfion. Recent studies have shown that IL-25 functions as an important mediator of Th2 responses and lies upstream of the classical Th2 cytokine responses. We recently discovered that Acti, a novel E3 ublquifin Iigase, is an essenfial signaling molecule for IL-25 signal transducfion and is recruited to the IL-25R upon ligand sfimulafion. Interesfingly, Acti deficiency in epithelial cells effecfively attenuates IL-25-mediated allergic pulmonary inflammafion, and Acti deficiency in T cells also results in significanfiy diminished Th2 responses and lung inflammafion. Based on these findings, we hypothesize that the IL-25 induced Actlmediated signaling pathway is essenfial for Th2 cell responses and allergic pulmonary inflammafion through disfinct effects on epithelial and T cell compartments. To test this, we propose two Specific Aims. First, we invesfigate the mechanisfic role of IL-25-induced Acti-mediated signaling pathway in Th2 responses and allergic pulmonary inflammafion. Second, we determine the molecular mechanism by which Acti mediates IL-25 signaling. In accord with the translafional goals of our TPPG, we use the Informafion obtained in this project to develop decoy (inhibitory) peptides to disrupt the Acti-IL-25 receptor interaction. Decoy inhibitory pepfides in the IL-25 signal transduction pathway are explored as a new therapeutic strategy for allergic pulmonary inflammafion. Project 2 benefits significantly from interacfions with other projects in the TPPG, and relies heavily on TPPG Cores for resources such as human and murine ainway organotypic cultures. Altogether, the TPPG fosters the translation of Project 2 bench research studies to development of novel patient therapeufics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL103453-01
Application #
7982564
Study Section
Special Emphasis Panel (ZHL1-CSR-A (M1))
Project Start
Project End
Budget Start
2011-08-02
Budget End
2012-06-30
Support Year
1
Fiscal Year
2011
Total Cost
$413,004
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Herjan, Tomasz; Hong, Lingzi; Bubenik, Jodi et al. (2018) IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol 19:354-365
Sweeny, Elizabeth A; Singh, Anuradha Bharara; Chakravarti, Ritu et al. (2018) Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells. J Biol Chem 293:14557-14568
Reichard, Andrew; Wanner, Nicholas; Stuehr, Eric et al. (2018) Quantification of airway fibrosis in asthma by flow cytometry. Cytometry A 93:952-958
Asosingh, Kewal; Weiss, Kelly; Queisser, Kimberly et al. (2018) Endothelial cells in the innate response to allergens and initiation of atopic asthma. J Clin Invest 128:3116-3128
Reichard, Andrew; Asosingh, Kewal (2018) The role of mitochondria in angiogenesis. Mol Biol Rep :
Yang, Hui; Zhu, Yun; Chen, Xing et al. (2018) Structure of a prokaryotic SEFIR domain reveals two novel SEFIR-SEFIR interaction modes. J Struct Biol 203:81-89
Cai, Gang; Zhu, Liang; Chen, Xing et al. (2018) TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation. Proc Natl Acad Sci U S A 115:11531-11536
Stober, Vandy P; Johnson, Collin G; Majors, Alana et al. (2017) TNF-stimulated gene 6 promotes formation of hyaluronan-inter-?-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness. J Biol Chem 292:20845-20858
Husta, Bryan C; Raoof, Suhail; Erzurum, Serpil et al. (2017) Tracheobronchopathy From Inhaled Corticosteroids. Chest 152:1296-1305
Chen, Jiwang; Sysol, Justin R; Singla, Sunit et al. (2017) Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension. Circulation 135:1532-1546

Showing the most recent 10 out of 136 publications